fluoxetine has been researched along with ergoline in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (31.25) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jørgensen, H; Knigge, U; Warberg, J | 1 |
| Robertson, DW; Threlkeld, PG; Wong, DT | 1 |
| Lemberger, L | 1 |
| Eisenberg, RM; Knych, ET | 1 |
| Broekkamp, CL; Garrigou, D; LLoyd, KG | 1 |
| Marsden, CA; Stolz, JF | 1 |
| Fingerman, M; Hanumante, MM | 1 |
| Borsini, F; Ceci, A; Cesana, R; Ciprandi, C | 1 |
| Hietala, J; Kuoppamäki, M; Laakso, A; Pälvimäki, EP; Syvälahti, E | 1 |
| Black, KJ; Sheline, YI | 1 |
| Chen, Y; Hertz, L; Kong, EK; Peng, L; Yu, AC | 1 |
| Sugimoto, Y; Yamada, J | 1 |
| Badauê-Passos, D; Olivares, EL; Reis, LC; Silva, LF; Ventura, RR | 1 |
| Hietala, J; Majasuo, H; Pälvimäki, EP; Syvälahti, E | 1 |
| Csoka, AB; Shipko, S | 1 |
| Homma, I; Kanamaru, M | 1 |
1 trial(s) available for fluoxetine and ergoline
| Article | Year |
|---|---|
Personality disorder scores improve with effective pharmacotherapy of depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Ergolines; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Disorders; Personality Inventory; Serotonin Antagonists | 1997 |
15 other study(ies) available for fluoxetine and ergoline
| Article | Year |
|---|---|
Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Animals; Dose-Response Relationship, Drug; Ergolines; Fluoxetine; Imidazoles; Indoles; Ketanserin; Male; Methysergide; Ondansetron; Prolactin; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Tropisetron | 1992 |
Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors.
Topics: Animals; Antidepressive Agents; Binding, Competitive; Cattle; Choroid Plexus; Ergolines; Fluoxetine; In Vitro Techniques; Male; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Stereoisomerism; Synaptosomes | 1991 |
Of mice and men: the extension of animal models to the clinical evaluation of new drugs.
Topics: Animals; Drug Evaluation; Drug Evaluation, Preclinical; Ergolines; Fluoxetine; Humans; Models, Biological; Pergolide; Pharmacology, Clinical; Rats | 1986 |
Effect of fluoxetine and metergoline on amphetamine-induced rise in plasma corticosterone.
Topics: Amphetamine; Animals; Corticosterone; Ergolines; Fluoxetine; Kinetics; Male; Metergoline; Propylamines; Rats | 1980 |
Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomised rats.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Clonidine; Ergolines; Fenfluramine; Fluoxetine; Imipramine; Male; Metergoline; Mianserin; Olfactory Bulb; Quipazine; Rats; Serotonin; Serotonin Antagonists | 1980 |
Behavioural effects of long term inhibition of 5-hydroxytryptamine receptors using metergoline.
Topics: Amitriptyline; Animals; Ergolines; Fluoxetine; Male; Metergoline; Motor Activity; Propranolol; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1981 |
5-Hydroxytryptaminergic control of red pigment-dispersing hormone release in the fiddler crab, Uca pugilator: effects of a 5-hydroxytryptamine uptake inhibitor and a 5-hydroxytryptamine receptor blocker on 5-hydroxytryptamine-induced and iproniazid-induce
Topics: Animals; Brachyura; Ergolines; Fluoxetine; Hormones; Iproniazid; Male; Pigments, Biological; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1981 |
Mesulergine antagonism towards the fluoxetine anti-immobility effect in the forced swimming test in mice.
Topics: Animals; Behavior, Animal; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Fluoxetine; Immobilization; Male; Mice; Neurotransmitter Uptake Inhibitors; Receptors, Serotonin; Swimming | 1993 |
Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus.
Topics: Amphetamines; Animals; Antiparkinson Agents; Autoradiography; Choroid Plexus; Citalopram; Ergolines; Fluoxetine; Image Processing, Computer-Assisted; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Up-Regulation | 1996 |
Up-regulation of 5-HT2B receptor density and receptor-mediated glycogenolysis in mouse astrocytes by long-term fluoxetine administration.
Topics: Animals; Astrocytes; Carrier Proteins; Cells, Cultured; Drug Administration Schedule; Ergolines; Fluoxetine; Glycogen; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Nerve Tissue Proteins; Protein Isoforms; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Up-Regulation | 2002 |
Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
Topics: Adrenergic Uptake Inhibitors; Animals; Brain; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Fluoxetine; Fluvoxamine; Male; Maprotiline; Mice; Motor Activity; Neurons; Norepinephrine; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Synaptic Transmission | 2002 |
Effect of brain serotoninergic stimulation on sodium appetite of euthyroid and hypothyroid rats.
Topics: Animals; Appetite Regulation; Brain; Drinking; Ergolines; Fenfluramine; Fluoxetine; Hypothyroidism; Male; Methimazole; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sodium Chloride, Dietary | 2003 |
Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
Topics: Amphetamines; Animals; Choroid Plexus; Citalopram; Dose-Response Relationship, Drug; Ergolines; Fluoxetine; Hydrolysis; Inositol Phosphates; Male; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Second Messenger Systems; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2005 |
Persistent sexual side effects after SSRI discontinuation.
Topics: Adult; Androgens; Anxiety; Bupropion; Cabergoline; Citalopram; Depressive Disorder; Dopamine Agonists; Dopamine Uptake Inhibitors; Ergolines; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Piperazines; Plants, Medicinal; Purines; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sleep Initiation and Maintenance Disorders; Sulfones; Testosterone; Time Factors; Treatment Outcome; Vasodilator Agents | 2006 |
Compensatory airway dilation and additive ventilatory augmentation mediated by dorsomedial medullary 5-hydroxytryptamine 2 receptor activity and hypercapnia.
Topics: Airway Resistance; Animals; Carbon Dioxide; Ergolines; Fluoxetine; Hypercapnia; Hypoglossal Nerve; Male; Mice; Mice, Inbred C57BL; Receptors, Serotonin, 5-HT2; Respiratory Mechanics; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Solitary Nucleus | 2007 |